Multi-Ingredient Preworkout Supplement on Peak Torque and Muscle Activation During Fatigue
NCT ID: NCT07217210
Last Updated: 2025-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2021-11-15
2022-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Peak Force At Long and Short Muscle Lengths and the Impact on Muscle Growth and Strength
NCT06666127
The Effects of HMB, ATP, and HMB Plus ATP on Muscle Mass, Strength, and Power in Resistance Trained Athletes
NCT01508338
Effects of Foam Rolling Versus Stretching Exercises on Quadriceps, Hamstrings and Calf Muscle Length
NCT05026931
Effects of Eccentric Hamstring Training in Prevention of Hamstring Injuries in Sprinters
NCT05789277
The Effects of β-Hydroxy-β-methylbutyrate Free Acid and High-Intensity Interval Training
NCT01941368
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The vast majority of previous investigations examining the acute effects of MIPS on performance have focused on isotonic variables of upper and lower body muscular strength \[i.e. bench press, leg press, and squat one-repetition maximum (1-RM), maxi-mum voluntary contractions (MVC)\], endurance (i.e. repetitions to failure at %1-RM), and power (vertical jump, Wingate Anaerobic testing, and critical power) \[1-6,9,12,18,19\]. Despite conflicting evidence for maximal force and power production \[4,6,20,21\], the findings of several studies \[1,3,4,12,17-19,22,23\] have largely indicated acute MIPS supplementation can enhance overall force retention and muscular endur-ance during prolonged or intermittent bouts of high intensity activity. Currently, how-ever, the exact underlying mechanisms responsible for these benefits on neuromuscular function are poorly understood.
Isokinetic dynamometers coupled with surface electromyography (EMG) record-ings are two frequently utilized instruments for the non-invasive assessment of neu-romuscular function and fatigue during static and dynamic muscle actions \[24-27\]. The utility of isokinetic testing involves the ability to measure isometric, concentric, and eccentric torque levels across an entire range of motion at controlled velocities with minimal skill involvement required. Results from isokinetic testing can provide torque production at different joint angles, while identifying muscle imbalances, tracking the recovery process from injury or surgery, and measuring the rate of force development \[28,29\]. Thus, as both a training and assessment tool, isokinetic testing is common in clinical and performance settings.
Surface electromyography (EMG) is a technique that involves recording and quantifying the action potentials associated with contracting skeletal muscle fibers \[30\]. The amplitude contents of the EMG signal reflect the level of muscle activation (i.e. motor unit recruitment and firing rates) \[31\], whereas the frequency contents pro-vide information related to the muscle fiber conduction velocity \[32\]. To our knowledge, only one study \[5\] has directly examined EMG responses associated with acute MIPS administration. Specifically, Negro et al. \[5\] reported acute MIPS (creatine, arginine, β-alanine, glutamine, taurine) ingestion improved EMG-based indicators of fatigue (i.e. conduction velocity, fractal dimension) during sustained isometric contrac-tions following a resistance exercise protocol designed to elicit fatigue. The authors \[5\] proposed these acute benefits of their MIPS product may be attributable to improved: 1) peripheral components of performance fatiguability, 2) buffering capacity of the mus-cle from β-alanine, and 3) regulation of mechanisms associated with exercise-induced fatigue from arginine, glutamine, and taurine. Based on these findings \[5\], valuable in-sight can be gained into the underlying neuromuscular factors associated with MIPS ingestion by examining muscle function and fatigue through isokinetic and EMG as-sessments. Thus, the primary purpose of the present study was to examine the acute ef-fects of a MIPS product on peak torque production of the leg extensors during a fatigu-ing isokinetic protocol involving isometric, concentric, and eccentric muscle actions. In addition, we investigated the effects of the MIPS supplement on EMG amplitude and median power frequency (MDF) responses from the vastus lateralis, rectus femoris, and vastus medialis muscles.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supplement group
Multi-ingredient preworkout supplement
Multi-ingredient preworkout supplement
Experimental supplement.
Placebo group
Microcystalline cellulose
Multi-ingredient preworkout supplement
Experimental supplement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multi-ingredient preworkout supplement
Experimental supplement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
29 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northern Illinois University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clayton Camic, PHD
Role: PRINCIPAL_INVESTIGATOR
Northern Illinois University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northern Illinois University
DeKalb, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
#HS22-0139
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.